Waël Zeinyeh

Converting Potent Indeno[1,2-<i>b</i>]indole Inhibitors of Protein Kinase CK2 into Selective Inhibitors of the Breast Cancer Resistance Protein ABCG2

Gustavo Jabor Gozzi, Zouhair Bouaziz, Evelyn Winter et al. · Journal of Medicinal Chemistry · 2014 · 77 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

In Silico, in Vitro, and in Vivo Evaluation of New Candidates for α-Synuclein PET Imaging

Mathieu Verdurand, Elise Levigoureux, Waël Zeinyeh et al. · Molecular Pharmaceutics · 2018 · 59 citations · Full text

Medicine, Medicinal Chemistry, Nuclear Medicine +14

Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co–crystal structure

Yannick J. Esvan, Waël Zeinyeh, Thibaut Boibessot et al. · European Journal of Medicinal Chemistry · 2016 · 42 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +16

New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis

Helmi Tazarki, Waël Zeinyeh, Yannick J. Esvan et al. · European Journal of Medicinal Chemistry · 2019 · 41 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Preparation and characterization of CK2 inhibitor-loaded cyclodextrin nanoparticles for drug delivery

Florent Perret, Christelle Marminon, Waël Zeinyeh et al. · International Journal of Pharmaceutics · 2012 · 26 citations

Pharmacy, Pharmaceutics, Pharmacology +12